istock-506815322_artjazz
artjazz / iStockphoto.com
18 April 2019Generics

European Parliament approves SPC manufacturing waiver

The European Parliament has voted to approve the supplementary protection certificate (SPC) manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
19 February 2019   While the final text of the European Council’s agreement on a supplementary protection certificate manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism.
Generics
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
Big Pharma
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.

More on this story

Big Pharma
19 February 2019   While the final text of the European Council’s agreement on a supplementary protection certificate manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism.
Generics
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
Big Pharma
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.

More on this story

Big Pharma
19 February 2019   While the final text of the European Council’s agreement on a supplementary protection certificate manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism.
Generics
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
Big Pharma
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.